Fasturtec TLS Treatment / Prophylysis

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

July 31, 2004

Conditions
Tumor Lysis Syndrome
Interventions
DRUG

urate oxidase

First injection of Rasburicase will be done the day of initiation of chemotherapy, or the day before, according to hyperuricemia. Additional doses are permitted q12h during the first 72 hours of chemotherapy if hyperuricemia persists or subject is considered to be at significant risk of tumor lysis complications.

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00651911 - Fasturtec TLS Treatment / Prophylysis | Biotech Hunter | Biotech Hunter